Abstract
Neuronuclear imaging has been utilized for several decades in the study of primary neurodegenerative conditions, such as dementia and parkinsonian syndromes, both for research and clinical purposes. There has been a relative paucity of application of neuronuclear imaging to evaluate non-neurodegenerative conditions that can also have long-term effects on cognition and function. This article summarizes clinical and imaging aspects of three such conditions that have garnered considerable attention in recent years: 1) cancer- and chemotherapy-related cognitive impairment, 2) post-traumatic stress disorder, and 3) traumatic brain injury. Further, we describe current research using neuroimaging tools aimed to better understand the relationships between the clinical presentations and brain structure and function in these conditions.
- Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.